PAPPONE, CARLO
 Distribuzione geografica
Continente #
AS - Asia 8.655
EU - Europa 8.115
NA - Nord America 6.240
SA - Sud America 2.897
AF - Africa 246
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 6
Totale 26.174
Nazione #
US - Stati Uniti d'America 5.939
RU - Federazione Russa 4.877
SG - Singapore 3.303
CN - Cina 2.433
BR - Brasile 2.361
HK - Hong Kong 1.077
SE - Svezia 956
VN - Vietnam 952
IT - Italia 446
FR - Francia 431
DE - Germania 278
RO - Romania 269
IE - Irlanda 225
FI - Finlandia 204
AR - Argentina 196
IN - India 176
GB - Regno Unito 144
BD - Bangladesh 136
ID - Indonesia 112
MX - Messico 109
CA - Canada 108
EC - Ecuador 92
IQ - Iraq 79
ZA - Sudafrica 74
CO - Colombia 67
AT - Austria 58
TR - Turchia 48
VE - Venezuela 45
PK - Pakistan 43
PL - Polonia 42
PY - Paraguay 42
NL - Olanda 40
JP - Giappone 39
MA - Marocco 36
UZ - Uzbekistan 36
CL - Cile 34
SA - Arabia Saudita 32
UA - Ucraina 26
UY - Uruguay 26
ES - Italia 24
TN - Tunisia 24
DZ - Algeria 22
KE - Kenya 22
PH - Filippine 22
LT - Lituania 21
MD - Moldavia 21
PE - Perù 19
EG - Egitto 18
AZ - Azerbaigian 16
NP - Nepal 15
AE - Emirati Arabi Uniti 14
BO - Bolivia 14
JM - Giamaica 14
OM - Oman 14
DO - Repubblica Dominicana 13
JO - Giordania 13
KZ - Kazakistan 13
EU - Europa 12
CR - Costa Rica 10
MY - Malesia 10
HN - Honduras 9
PT - Portogallo 9
SN - Senegal 9
IR - Iran 8
LB - Libano 8
NI - Nicaragua 8
AL - Albania 7
BE - Belgio 7
ET - Etiopia 7
TT - Trinidad e Tobago 7
LY - Libia 6
QA - Qatar 6
AM - Armenia 5
GE - Georgia 5
KW - Kuwait 5
NG - Nigeria 5
SV - El Salvador 5
SY - Repubblica araba siriana 5
BB - Barbados 4
BH - Bahrain 4
GT - Guatemala 4
KR - Corea 4
AU - Australia 3
BG - Bulgaria 3
CD - Congo 3
CZ - Repubblica Ceca 3
IL - Israele 3
KG - Kirghizistan 3
LV - Lettonia 3
NO - Norvegia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BZ - Belize 2
CG - Congo 2
CH - Svizzera 2
CI - Costa d'Avorio 2
DK - Danimarca 2
DM - Dominica 2
GA - Gabon 2
Totale 26.124
Città #
Dallas 2.236
Singapore 1.250
Hong Kong 1.065
Moscow 1.018
San Jose 607
Ashburn 582
Shanghai 471
Hefei 459
Lawrence 428
Princeton 427
Ho Chi Minh City 390
Lauterbourg 386
Dublin 225
São Paulo 188
Hanoi 186
Helsinki 171
Beijing 165
New York 146
Milan 121
Los Angeles 76
Rio de Janeiro 73
Nuremberg 64
Orem 61
Santa Clara 59
Boardman 53
Brasília 44
Curitiba 44
Belo Horizonte 42
Da Nang 42
Munich 42
Haiphong 41
Chennai 40
Porto Alegre 38
Johannesburg 37
Warsaw 37
Denver 34
Rome 34
Guangzhou 33
Tianjin 33
Tokyo 33
Salvador 32
Tashkent 32
Baghdad 31
Frankfurt am Main 31
London 31
Guayaquil 30
Atlanta 29
Brooklyn 29
Toronto 29
Campinas 28
Manchester 27
Phoenix 26
Seattle 26
Stockholm 26
Chicago 25
Pune 25
Vienna 25
Biên Hòa 24
Quito 24
Hangzhou 23
Poplar 23
Amsterdam 21
Montevideo 21
Montreal 21
Washington 21
Buenos Aires 20
Jakarta 20
Nairobi 20
Asunción 19
Boston 19
Caxias do Sul 19
Goiânia 19
Santo André 19
Council Bluffs 18
Guarulhos 18
Hải Dương 18
Osasco 18
Ribeirão Preto 18
Dhaka 17
Recife 17
San Francisco 17
Thái Nguyên 17
Ankara 16
Caracas 16
Fortaleza 16
Lappeenranta 16
Mexico City 16
Mumbai 16
Shenzhen 16
Sorocaba 16
Turku 16
Baku 15
Houston 15
Jeddah 15
Lahore 15
Aracaju 14
Formosa 14
New Delhi 14
Querétaro 14
Santiago 14
Totale 12.728
Nome #
1. Cardiac Resynchronization Therapy with Multisite Left Ventricular Pacing Improves Acute Hemodynamic Response in Patients 1.421
A comprehensive and easy-to-use ECG algorithm to predict the coronary occlusion site in ST-segment elevation myocardial infarction 223
A 20-joule electrical cardioversion applied directly to the heart elevates troponin I by at least 1.5 ng.mL(-1) 145
A Brugada Syndrome mutation (p.S216L) and its modulation by p.H558R polymorphism: standard and dynamic characterization 131
Brugada Syndrome: New Insights From Cardiac Magnetic Resonance and Electroanatomical Imaging 129
A controlled randomized trial of biatrial ablation for curing long-lasting permanent atrial fibrillation (the Decomplex Trial) 129
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society 129
Ablation catheter with flexible tip and methods of making the same 126
Challenges in Brugada Syndrome Stratification: Investigating SCN5A Mutation Localization and Clinical Phenotypes 125
65. Cardiac contractility modulation by nonexcitatory electrical currents for treating systolic heart failure early multicenter experience 124
2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design 124
Unravelling Novel SCN5A Mutations Linked to Brugada Syndrome: Functional, Structural, and Genetic Insights 118
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design 118
A simple way to treat chronic atrial fibrillation during mitral valve surgery: the epicardial radiofrequency approach 115
Human Sarcopenic Myoblasts Can Be Rescued by Pharmacological Reactivation of HIF-1α 114
Brugada syndrome genetics is associated with phenotype severity 114
A randomized study of prophylactic catheter ablation in asymptomatic patients with the Wolff-Parkinson-White Syndrome 113
Cell-Based Therapies for Cardiac Regeneration: A Comprehensive Review of Past and Ongoing Strategies 112
[A methodological approach to the transcatheter radiofrequency ablation of anomalous Kent-type pathways] 110
Ebstein's anomaly in children and adults: Multidisciplinary insights into imaging and therapy 108
[The physical and chemical principles of radiofrequency catheter ablation in arrhythmias] 106
[Atrioventricular conduction before and after the radiofrequency catheter ablation of a nodal reentry tachycardia circuit] 104
Analysis of the intramolecular 1,7-lactone of N-acetylneuraminic acid using HPLC–MS: relationship between detection and stability 103
[Ablation of paroxysmal tachycardia in Wolff-Parkinson-White syndrome] 103
Clinical characteristics and electrophysiologic properties of SCN5A variants in fever-induced Brugada syndrome 102
“Cardiac Resynchronization Therapy” 101
“How to Perform Circumferential Pulmonary Vein Ablation with Electroanatomical Guidance” 101
A randomized study of prophyl actic catheter ablation in high-risk children with asymptomatic Wolff-Parkinson-White syndrome 100
Atrial fibrillation in autoimmune rheumatic diseases: From pathogenesis to treatment 100
“How to implant biventricular pacemakers in patients with heart failure” (basics and advanced techniques 99
“Theory and Practice of Catheter Ablation of Atrial Fibrillation. Seven different cases” 98
Brugada Syndrome: Warning of a Systemic Condition? 97
[Radiofrequency catheter ablation of atrial tachycardia: technique, results and follow-up] 96
[Prospects of the treatment of atrial fibrillation. Circumferential radiofrequency ablation of pulmonary vein ostia] 95
A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study 95
HIF-1α Directly Controls WNT7A Expression During Myogenesis 94
GM1 Ganglioside Promotes Osteogenic Differentiation of Human Tendon Stem Cells 93
Atrial fibrillation detection using a novel three-vector cardiac implantable monitor: The atrial fibrillation detect study 93
Comparable clinical characteristics in Brugada syndrome patients harboring SCN5A or novel SCN10A variants 92
Calcium in Brugada syndrome: Questions for future research 92
“Stroke Prevention: Left Atrial Appendage Occlusion” 90
Brugada Syndrome Phenotype Elimination by Epicardial Substrate Ablation 90
Clinical considerations for a family with dilated cardiomyopathy, sudden cardiac death, and a novel ttn frameshift mutation 89
Second-generation laser balloon ablation for the treatment of atrial fibrillation assessed by continuous rhythm monitoring: the LIGHT-AF study 88
Sphingolipids and Atherosclerosis: The Dual Role of Ceramide and Sphingosine-1-Phosphate 87
“Circumferential Pulmonary Vein Ablation With MediGuide® System” 86
“Management of Advanced Atrial Fibrillation” 85
The antithetic role of ceramide and sphingosine-1-phosphate in cardiac dysfunction 85
Neu3 Sialidase Activates the RISK Cardioprotective Signaling Pathway during Ischemia and Reperfusion Injury (IRI) 84
Course Syllabus: “Theory and Practice of Catheter Ablation of Atrial Fibrillation 2002” 84
Updated national multicenter registry on procedural safety of catheter ablation for atrial fibrillation 84
Brugada Syndrome: Oligogenic or Mendelian Disease? 81
Left Atrial Dynamics During Exercise in Mitral Regurgitation of Primary and Secondary Origin: Pathophysiological Insights by Exercise Echocardiography Combined With Gas Exchange Analysis 80
Dynamic programming of atrioventricular delay improves electrical synchrony in a multicenter cardiac resynchronization therapy study 80
Antitachycardia devices for the treatment of recurrent ventricular tachycardia: long term results 79
Automated Patch-Clamp and Induced Pluripotent Stem Cell-Derived Cardiomyocytes: A Synergistic Approach in the Study of Brugada Syndrome 78
Follow-up of a respiratory rate modulated pacemaker 78
Genotype/Phenotype Relationship in a Consanguineal Family With Brugada Syndrome Harboring the R1632C Missense Variant in the SCN5A Gene 78
Design, Synthesis, and Antiviral Evaluation of Sialic Acid Derivatives as Inhibitors of Newcastle Disease Virus Hemagglutinin-Neuraminidase: A Translational Study on Human Parainfluenza Viruses 77
Stereotaxis “Atrial Fibrillation Ablation” 77
HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA) 77
Novel scn5a p.V1429m variant segregation in a family with brugada syndrome 76
Intermittent alternance of Brugada ECG patterns: Insights from a unique electrophysiological phenomenon 76
Radiofrequency Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation Meta-Analysis of Quality of Life, Morbidity, and Mortality 76
Management of severe cardiac arrhythmic events in elite athletes 75
The APAF study: A controlled randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy for curing paroxysmal atrial fibrillation: The ablation for paroxysmal atrial fibrillation (APAF) trial [Die APAF-studie: A controlled randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy for curing paroxysmal atrial fibrillation: The ablation for paroxysmal atrial fibrillation (APAF) trial] 75
Clinical outcome of electrophysiologically guided ablation for nonparoxysmal atrial fibrillation using a novel real-time 3-dimensional mapping technique results from a prospective randomized trial 74
NaV1.5 autoantibodies in Brugada syndrome: pathogenetic implications 73
Helical superstructures between amyloid and collagen in cardiac fibrils from a patient with AL amyloidosis 73
Low incidence of permanent complications during catheter ablation for atrial fibrillation using open-irrigated catheters: A multicentre registry 73
Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation 72
Sphingolipid synthesis inhibition by myriocin administration enhances lipid consumption and ameliorates lipid response to myocardial ischemia reperfusion injury 71
Should catheter ablation be performed in asymptomatic patients with Wolff-Parkinson-White syndrome? When to perform catheter ablation in asymptomatic patients with a Wolff-Parkinson-White electrocardiogram 70
Prospective European survey on atrial fibrillation ablation: Clinical characteristics of patients and ablation strategies used in different countries 70
Right ventricular epicardial arrhythmogenic substrate in long-QT syndrome patients at risk of sudden death 69
Commentary: Next generation sequencing and linkage analysis for the molecular diagnosis of a novel overlapping syndrome characterized by hypertrophic cardiomyopathy and typical electrical instability of brugada syndrome 69
Primary atrial tachycardia: techniques for intracardiac mapping and radiofrequency ablation 69
Atrial fibrillation progression and management: a 5-year prospective follow-up study 69
Quantitative assessment of left ventricular contractile synchrony during biventricular pacing using color kinesis echocardiography 68
Atrial fibrillation in elite athletes 68
Asymptomatic ventricular preexcitation: a long-term prospective follow-up study of 293 adult patients 68
Novel JAG1 deletion variant in patient with atypical alagille syndrome 68
Assessing QT interval in COVID-19 patients:safety of hydroxychloroquine-azithromycin combination regimen 68
Regenerating the human heart : direct reprogramming strategies and their current limitations 67
Deep learning unmasks the ECG signature of Brugada syndrome 66
Electrical Substrate Elimination in 135 Consecutive Patients with Brugada Syndrome 66
Fibroma of the left ventricle in a patient with Sotos syndrome 65
Cardiac magnetic resonance with implanted monitor 65
Novel scn5a p.Val1667asp missense variant segregation and characterization in a family with severe brugada syndrome and multiple sudden deaths 65
Case Report: Efficacy of Rituximab in a Patient With Familial Mediterranean Fever and Multiple Sclerosis 65
Assessing the Malignant Ventricular Arrhythmic Substrate in Patients With Brugada Syndrome 64
New electromechanical substrate abnormalities in high-risk patients with Brugada syndrome 64
Non-invasive assessment of the arrhythmogenic substrate in Brugada syndrome using signal-averaged electrocardiogram: Clinical implications from a prospective clinical trial 64
Interplay of Modified Sialic Acid Inhibitors and the Human Parainfluenza Virus 1 Hemagglutinin-Neuraminidase Active Site 63
Circumferential pulmonary-vein ablation for chronic atrial fibrillation 63
Long-term outcome of remote catheter ablation using a magnetic irrigated-tip catheter 63
High-Risk Arrhythmic presenting profile did not predict the need for defibrillation backup in cardiac resynchronization therapy patients 63
First human chronic experience with cardiac contractility modulation by nonexcitatory electrical currents for treating systolic heart failure: Mid-term safety and efficacy results from a multicenter study 62
Efficacy of radiofrequency catheter ablation of accessory pathway in patients with previous unsuccessful surgical ablation 62
Feasibility of Remote Monitoring Using a Novel Long-Dipole Insertable Cardiac Monitor 62
Totale 10.188
Categoria #
all - tutte 171.669
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 171.669


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022173 0 0 0 90 8 9 19 3 22 2 13 7
2022/20232.257 1.071 444 106 18 6 180 223 76 83 32 14 4
2023/2024563 39 23 59 78 39 69 14 57 0 28 38 119
2024/20255.661 834 79 26 77 121 387 824 454 1.149 896 373 441
2025/202617.680 1.066 1.662 2.525 2.910 1.037 476 1.274 1.081 4.313 968 365 3
Totale 26.761